BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Lymphoma AND ABL1, p150, 25, ENSG00000097007, P00519, v-abl, bcr/abl, JTK7, c-ABL, ABL, BCR-ABL AND Prognosis
2146 results:

  • 1. Colosplenic fistula diagnosis and management: a case series and review of literature.
    Hernandez Dominguez O; Lincango EP; Spivak R; Almonacid-Cardenas F; Prien C; Uchino T; Spivak A; Hull TL; Steele SR; Holubar SD
    Int J Surg; 2024 Apr; 110(4):2381-2388. PubMed ID: 38668664
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. MNDA expression and its value in differential diagnosis of B-cell non-Hodgkin lymphomas: a comprehensive analysis of a large series of 1293 cases.
    Zhang LF; Zhang Y; Shui RH; Lu HF; Jiang WH; Cai X; Li XQ; Yu BH
    Diagn Pathol; 2024 Apr; 19(1):60. PubMed ID: 38627702
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. A review of immunotargeted therapy for Philadelphia chromosome positive acute lymphoblastic leukaemia: making progress in chemotherapy-free regimens.
    Xiong ZY; Shen YJ; Zhang SZ; Zhu HH
    Hematology; 2024 Dec; 29(1):2335856. PubMed ID: 38581291
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Babaodan overcomes cisplatin resistance in cholangiocarcinoma via inhibiting YAP1.
    Li J; Ma X; Xu F; Yan Y; Chen W
    Pharm Biol; 2024 Dec; 62(1):314-325. PubMed ID: 38571483
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Extracellular matrix protein 1 (ECM1) is a potential biomarker in B cell acute lymphoblastic leukemia.
    Wu LX; Zhao MY; Yan N; Zhou YL; Cao LM; Qin YZ; Jiang Q; Xu LP; Zhang XH; Huang XJ; Jiang H; Ruan GR
    Clin Exp Med; 2024 Mar; 24(1):56. PubMed ID: 38546916
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Acute Lymphoblastic Leukemia With Near-haploid Karyotype and Philadelphia Chromosome.
    Panagopoulos I; Andersen K; Wik HS; Tandsæther MR
    Anticancer Res; 2024 Apr; 44(4):1389-1397. PubMed ID: 38537997
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. The potential value of ultrasound in predicting local refractory/relapse events in primary thyroid lymphoma patients.
    Ji J; Gao L; Liu R; Shi X; Ma L; Pan A; Li N; Liu C; Li X; Yang M; Xia Y; Jiang Y
    Cancer Imaging; 2024 Mar; 24(1):39. PubMed ID: 38509603
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Clinical Management of Patients with Non-Small Cell Lung Cancer, Brain Metastases, and Actionable Genomic Alterations: A Systematic Literature Review.
    Khasraw M; Yalamanchili P; Santhanagopal A; Wu C; Salas M; Meng J; Karnoub M; Esker S; Felip E
    Adv Ther; 2024 May; 41(5):1815-1842. PubMed ID: 38509433
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Survival Outcome and Prognostic Factors of Primary Spinal Cord lymphoma.
    Qianjin D; Zhenguo C; Yang W; Baoshun D; Laiguang S
    Turk Neurosurg; 2024; 34(2):216-223. PubMed ID: 38497173
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Matching-Adjusted Indirect Comparison of Brexucabtagene Autoleucel (ZUMA-2) and Pirtobrutinib (BRUIN) in Patients with Relapsed/Refractory Mantle Cell lymphoma Previously Treated with a Covalent Bruton Tyrosine Kinase Inhibitor.
    Salles G; Chen JMH; Zhang I; Kerbauy F; Wu JJ; Wade SW; Nunes A; Feng C; Kloos I; Peng W; Snider JT; Maciel D; Chan K; Keeping S; Shah B
    Adv Ther; 2024 May; 41(5):1938-1952. PubMed ID: 38494543
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Pre-treatment [
    Chen J; Zhao Y
    Hematology; 2024 Dec; 29(1):2325317. PubMed ID: 38465661
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Integrated analysis of transcriptome and genome variations in pediatric T cell acute lymphoblastic leukemia: data from north Indian tertiary care center.
    Singh M; Sharma P; Bhatia P; Trehan A; Thakur R; Sreedharanunni S
    BMC Cancer; 2024 Mar; 24(1):325. PubMed ID: 38459434
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. ERG and c-MYC regulate a critical gene network in bcr::abl1-driven B cell acute lymphoblastic leukemia.
    Behrens K; Brajanovski N; Xu Z; Viney EM; DiRago L; Hediyeh-Zadeh S; Davis MJ; Pearson RB; Sanij E; Alexander WS; Ng AP
    Sci Adv; 2024 Mar; 10(10):eadj8803. PubMed ID: 38457494
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Prognostic and clinicopathological significance of the Controlling Nutritional Status (CONUT) score in patients with lymphoma: a meta-analysis.
    Li L; Shou L
    BMJ Open; 2024 Mar; 14(3):e078320. PubMed ID: 38453197
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. First report of familial mixed phenotype acute leukemia: shared clinical characteristics, Philadelphia translocation, and germline variants.
    Shiozawa Y; Fujita S; Nannya Y; Ogawa S; Nomura N; Kiguchi T; Sezaki N; Kudo H; Toyama T
    Int J Hematol; 2024 Apr; 119(4):465-471. PubMed ID: 38424413
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Prognostic significance of bone marrow fibrosis in diffuse large B-cell lymphoma.
    Cetintepe T; Ozkan G; Kucukzeybek BP; Cetintepe L; Unal DK; Solmaz S; Aygun K; Acar AG; Bener S; Çallı AO; Payzın KB
    Int J Lab Hematol; 2024 Jun; 46(3):523-530. PubMed ID: 38361314
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Hypercalcaemia of malignancy: a case of vitamin-D-mediated hypercalcaemia in lymphoma.
    Mehta K; Awan M; Devlin S; Jassal SK
    BMJ Case Rep; 2024 Feb; 17(2):. PubMed ID: 38320825
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
    Tam CS; Opat S; D'Sa S; Jurczak W; Lee HP; Cull G; Owen RG; Marlton P; Wahlin BE; García-Sanz R; McCarthy H; Mulligan S; Tedeschi A; Castillo JJ; Czyż J; Fernández De Larrea C; Belada D; Libby E; Matous J; Motta M; Siddiqi T; Tani M; Trněný M; Minnema MC; Buske C; Leblond V; Treon SP; Trotman J; Wu B; Yu Y; Shen Z; Chan WY; Schneider J; Allewelt H; Cohen A; Dimopoulos MA
    Blood Adv; 2024 Apr; 8(7):1639-1650. PubMed ID: 38315878
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Mediation of Ferroptosis Suppressor Protein 1 Expression via 4-Hydroxy-2-Nonenal Accumulation Contributes to Acquisition of Resistance to Apoptosis and Ferroptosis in Diffuse Large B-Cell lymphoma.
    Kawade G; Kurata M; Matsuki Y; Fukuda S; Onishi I; Kinowaki Y; Watabe S; Ishibashi S; Ikeda M; Yamamoto M; Ohashi K; Kitagawa M; Yamamoto K
    Lab Invest; 2024 Apr; 104(4):102027. PubMed ID: 38311062
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Predictive and prognostic molecular biomarkers in lymphomas.
    Iorgulescu JB; Medeiros LJ; Patel KP
    Pathology; 2024 Mar; 56(2):239-258. PubMed ID: 38216400
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 108.